BRCA1 and ovarian carcinoma: Ovarian cancer cell lines with BRCA1 mutated and impaired HR (UWB1.289, SNU-251, OVCAR8) exhibit higher sensitivity towards PARPi, when compared with cells with wild-type or restored BRCA1 (SKOV3, A2780PAR and A2780CR) [45].